Interaktionen pharmaka und harnblase: Therapieoptionen und unerwünschte effekte

Medizinische Welt

Volumn 47, Issue 12, 1996, Pages 498-503

  Zwergel, Ulrike ^a   Wullich, B ^a   Zwergel, Th ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Anticholinergic drugs; Side effects; Urinary retention; Voiding dysfunction

Indexed keywords

ADRENALIN; ANTIDEPRESSANT AGENT; ANTIPARKINSON AGENT; BIPERIDEN; CALCIUM ANTAGONIST; CHLORPROTHIXENE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLEMASTINE; CLOMIPRAMINE; DIMETINDEN; DISOPYRAMIDE; DOXEPIN; EMEPRONIUM; EMEPRONIUM BROMIDE; FLAVOXATE; HALOPERIDOL; IMIPRAMINE; INDOMETACIN; ISOPRENALINE; MAPROTILINE; NEUROLEPTIC AGENT; NIFEDIPINE; OXYBUTYNIN; PIPAMPERONE; PROMETHAZINE; PROPIVERINE; TERFENADINE; TERODILINE; THIORIDAZINE; TROPICAMIDE; TROSPIUM CHLORIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VERAPAMIL; VINCRISTINE;

ARTICLE; BLADDER DYSFUNCTION; DETRUSOR MUSCLE; HUMAN; URINARY TRACT DISEASE; URINE RETENTION;

EID: 3643083359     PISSN: 00258512     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Abrams P. Detrusor instability and bladder outlet obstruction. Neurourol Urodynam 1985; 4: 317-28.
2. Andersson KE, Ekman G, Henriksson L, Ulmsten U. The effect of midodrine and its aktive metabolite ST 1059 on the human urethra in vitro and in vivo. Scand J Urol Nephrol 1983; 17: 261-5.
3. Bors E, Comarr AE Neurological Urology. Karger, Basel 1971.
4. Bradley WE, Timm GW, Scott FB. Innervation of the detrusor muscle and urethra. Urol Clin N Amer 1974; 1: 3-27.
5. Bryden AA, Rothwell PJN, O'Reilly PH. Urinary retention with misuse of »ecstasy«. Br Med J 1995; 310: 504.
6. Cardozo LD, Stanton SL, Robinson H, Hole D. Evaluation of flubiprofen in detrusor instability. Brit Med J 1980; 280: 281-2.
7. Castleden CM, George CF, Renwick AG, Asher MJ. Imipramine a possible alternative to current therapy for incontinence in the elderly. J Urol 1981; 125: 318-20.
8. Fovaeus M, Andersson KE, Batra S, Morgan E, Sjögren C. Effects of calcium, calcium channel blockers and Bay K 8644 on contractions induced by muscarinic receptor stimulation of isolated bladder muscle from rabbit and man. J Urol 1987; 137: 798-803.
9. Friedman AJ. Acute urinary retention after gonadotropin releasing hormone agonist treatment for leiomyomata uteri. Fertility, Sterility 1993; 59: 677-8.
10. Fùllgraf G, Palm D. Pharmakotherapie; Klinische Pharmakologie. Fischer, Stuttgart 1995.
11. Gosling JA, Dixon JS, Lendon RG. The autonomic innervation of the human male and female bladder neck and proximal urethra. J Urol 1977; 118: 302-5.
12. Grüneberger A. Treatment of motor urge incontinence with clenbuterol and flavoxate hydrochloride. Brit J Obstet Gynaecol 1984; 91: 275-8.
13. Jünemann KP. Neurourologie und Urodynamik. In: Urologie. Alken P, Walz PH. VCH Weinheim 1992; 386-409.
14. Kohli-Kumar M, Pearson ADJ, Sharkey I, Craft AW. Urinary retention - an unusual dystonic reaction to continuous metoclopramide infusion. ICCP Ann Pharmacother 1991; 25: 469-70.
15. Maany J, Greenfield H, Dhopesh V, Woody G. Urinary retention as a possible complication of long-term diazepam abuse. Am J Psych 1991; 148: 685.
16. Madersbacher H, Stöhrer M, Richter R, Burgdörfer H, Hachen HJ, Mürtz G. Trospium chloride versus oxybutynin: a randomized double blind multicentre trial in the treatment of detrusor hyperreflexia. Br J Urol 1995; 75: 452-6.
17. Pras E, Stienlauf Sh, Pinkhas J, Sidi Y. Urinary retention associated with ipratropium bromide. DICP Ann P 1991; 25: 939-40.
18. Seggev JS, Fink JN. Urinary retention as a result of administration of terfenadine. J All Clin Immun 1994; 93: 1071-2.
19. Stöhrer M. In: Neurogene Blasenentleerimgsstörungen. Praxis der Urologie. Jocham D. Miller K. (Hrsg.). Stuttgart. New York: Thieme 1994; 257-75.
20. Stöhrer M, Frohneberg D, Löchner-Ernst D, Sauter P, Mandalka B. Oxybutynin in der Therapie der Detrusorhyperreflexie bei Patienten mit Rückenmarksverletzungen. Eine multizentrische randomisierte Doppelblindstudie. Presented at the Annual Meeting of the American spinal cord injury association 1990 (Abstract).
21. Thüroff JW, Bunke B, Ebner A, Faber P, de Geeter P, Hannappel J, Heidler H, Madersbacher H, Melchior H, Schafer W, Schwenker T, Stöckle M. Randomized double blind multicenter trial on treatment of frequency, urgency and incontinence related to detrusor hyperactivity - oxybutynin versus propantheline versus placebo. J Urol 1991; 145: 813-7.
22. Thüroff J. Stellungnahme des Arbeitskreises urologische Funktionsdiagnostik und Urologie der Frau zum Arzneiverordnungsreport 1993: Urologische Spasmolytika. DGU Mitteilungen 1995; 1: 20-3.
23. Zanollo A, Catanzaro F. Urodynamic response of unstable bladder to flavoxate. Urol Int 1980; 35: 176-81.
24. Zeegers AGM, Kiesswetter H, Kramer AEJL, Jonas U. Conservative therapy of frequency, urgency and urge incontinence: a double-blind clinical trial of flavoxate hydrochloride, oxybutynin chloride, emepronium bromide and placebo. Wld J Urol 1987; 5: 57-61.
25. Zweigel U, Zwergel T. Benigne Prostatahyperplasie - Was bringen neue Therapieformen? medwelt 1993; 44: 64-8.
26. Zwergel U, Jost WH, Lindenmeir T, Zwergel T. Blasenentleerungsstörungen bei Encephalomyelitis disseminata - medikamentöse und interventioneile Therapieoptionen. Fortschr Neurol Psychiat 1995; 63: 495-503.